Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.066,08
0,28%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fusion Pharmaceuticals Inc (FUSN) Fusion Pharmaceuticals Inc (FUSN) Notizie

Fusion Pharmaceuticals Inc

FUSN
21,44
-0,05 (-0,23%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202419:56PRNUSKuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to..
25/4/202422:34PRNUSFusion Pharmaceuticals Mails Circular for Special Meeting of..
09/4/202422:05PRNCAFusion Pharmaceuticals Announces Presentation of Interim..
20/3/202421:10PRNUSKuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to..
20/3/202421:05PRNCAFusion Pharmaceuticals Reports Fourth Quarter and Full Year..
19/3/202408:00PRNUSFusion Pharmaceuticals to be Acquired by AstraZeneca,..
06/3/202413:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/3/202422:43PRNUSFusion Pharmaceuticals to Present Interim Data from the..
26/2/202413:45PRNCAFusion Pharmaceuticals to Present at Upcoming March Investor..
16/2/202422:05EDGAR2Form 8-K - Current report
16/2/202414:45PRNUSFusion Pharmaceuticals Enters into Exclusive Worldwide..
07/2/202413:45PRNUSFusion Pharmaceuticals to Present at the Oppenheimer 34th..
06/2/202422:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
19/1/202422:13EDGAR2Form 8-K - Current report
19/1/202422:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202414:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
05/1/202400:53DJNShares of Fusion Pharmaceuticals Rise 7.8% With Study..
04/1/202422:31EDGAR2Form 8-K - Current report
04/1/202422:05PRNUSFusion Pharmaceuticals Announces Clinical Program and..
16/11/202312:45BWBWXT Medical Expands Collaboration with Fusion..
08/11/202322:15PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
08/11/202314:15PRNCAFusion Pharmaceuticals to Present at Upcoming Investor..
07/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:45EDGAR2Form 8-K - Current report
07/11/202313:00PRNCAFusion Pharmaceuticals Announces Third Quarter 2023..
16/10/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202322:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/10/202322:30EDGAR2Form 8-K - Current report
16/10/202313:50PRNCAFusion Pharmaceuticals Appoints Life Science Industry..
12/10/202313:45PRNUSFusion Pharmaceuticals Announces Presentation of Preclinical..
06/9/202322:25PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/9/202322:10PRNCAFusion Pharmaceuticals to Present at Upcoming September..
09/8/202322:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
08/8/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:30EDGAR2Form 8-K - Current report
08/8/202313:00PRNUSFusion Pharmaceuticals Announces Second Quarter 2023..
06/7/202322:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
26/6/202314:05PRNCAFusion Pharmaceuticals to Present Interim Data from Phase 1..
16/6/202314:05PRNCAFusion Pharmaceuticals to Present at the TD Cowen..
07/6/202313:35PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
31/5/202322:10PRNUSFusion Pharmaceuticals to Present at the Jefferies..
11/5/202313:15PRNUSFusion Pharmaceuticals Announces First Quarter 2023..
09/5/202313:45PRNUSFusion Pharmaceuticals to Present at the Guggenheim..
Apertura: 21,50 Min: 21,43 Max: 21,51
Chiusura: 21,49

La tua Cronologia

NASDAQ
FUSN
Fusion Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network